|Click on the figure to enlarge it.|
November 16, 2012
$PVCT.OB: The SPA's Supportive Programmatic Elements
Per Provectus' October 2 PR, "[t]he study duration is estimated to be approximately 30 months, with commencement expected in late 2012 or early 2013 following completion of review for SPA." As such, management expects the SPA would arrive in November/December ("late 2012") or January/February ("early 2013").
I think the article below is instructive when trying to understand (a) the delay from Q3 to Q4 2012 or Q1 2013 and (b) Dr. Wachter's quote above -- "...and fostered relationships with key parties that will provide support in execution of the Phase 3 study."